Neurohydrate & Theromics

Beacon Angels entertained funding proposals from the following companies at its meeting on Tuesday, January 8, 2019:

  • Neurohydrate which offers a nutritional supplement to help migraine sufferers mitigate the gastrointestinal side effects of treatments, and
  • Theromics, which offers a platform for surgeons and oncologists to thermally ablate cancerous tumors, potentially cutting recurrence from an average of 30% to zero.

Beacon also heard portfolio company updates and members’ due diligence reports on potential new investments.

About Beacon Angels

Angel group, founded in 2006, that invests in early stage start-up companies--New England based only.
This entry was posted in Beacon Angels Events, Boston angel investing, Boston Startups, Funding Presentations, Private Equity, Uncategorized. Bookmark the permalink.